Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Neurofibroma, Plexiform × pirfenidone × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neurofibromatosis 1 1 Neurofibroma, Plexiform 1 Nerve Sheath Neoplasms 1 Lymphedema 1

Interventions

tipifarnib 1 pirfenidone 1 peginterferon alfa-2b 1 nilotinib 1 mirdametinib 1 cediranib 1 cabozantinib 1 binimetinib 1 Vinblastine 1 Methotrexate 1 Gadolinium DTPA 1 Fluorodeoxyglucose F18 1 Everolimus 1 Acceptance and Commitment Therapy 1 AZD 6244 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00076102 2018-04-23

Pirfenidone in Children and Young Adults With Neurofibromatosis Type I and Progressive Plexiform Neurofibromas

National Institutes of Health Clinical Center (CC)

Phase 2 Completed

36 enrolled 13 charts

Neurofibromatosis 1, Nerve Sheath Neoplasms, Neurofibroma, Plexiform

Data powered by HemOnc (CC BY 4.0) Colophon ⚡